| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | - | 9.437 | - | 21.464 | - | 31.094 | 44.736 | 53.798 | - | - |
| Total Income - EUR | - | 9.437 | - | 21.464 | - | 31.094 | 44.736 | 53.798 | - | - |
| Total Expenses - EUR | - | 2.371 | - | 11.960 | - | 27.849 | 31.753 | 42.989 | - | - |
| Gross Profit/Loss - EUR | - | 7.066 | - | 9.504 | - | 3.245 | 12.983 | 10.809 | - | - |
| Net Profit/Loss - EUR | - | 6.878 | - | 9.313 | - | 2.955 | 12.480 | 10.521 | - | - |
| Employees | - | 1 | - | 2 | - | 3 | 3 | 3 | - | - |
Check the financial reports for the company - Finest Medical Experts Srl
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | - | 0 | - | 0 | - | 0 | 0 | 0 | - | - |
| Current Assets | - | 7.060 | - | 33.215 | - | 28.142 | 48.533 | 60.397 | - | - |
| Inventories | - | 0 | - | 0 | - | 0 | 0 | 0 | - | - |
| Receivables | - | 1.268 | - | 4.192 | - | 429 | 32.258 | 34.656 | - | - |
| Cash | - | 5.793 | - | 29.023 | - | 27.714 | 16.275 | 25.741 | - | - |
| Shareholders Funds | - | 6.922 | - | 17.171 | - | 28.138 | 48.533 | 59.205 | - | - |
| Social Capital | - | 45 | - | 43 | - | 41 | 40 | 41 | - | - |
| Debts | - | 138 | - | 16.044 | - | 4 | 0 | 1.192 | - | - |
| Income in Advance | - | 0 | - | 0 | - | 0 | 0 | 0 | - | - |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "8690 - 8690" | |||||||||
| CAEN Financial Year |
8690
|
|||||||||
Comments - Finest Medical Experts Srl